|Seminars are presented by AFRRI researchers and other members of the scientific community. While some seminars are open to the public, others are limited to specific audiences. Any exceptions to time, place, and admittance are noted with each item. We do not record or distribute information presented in our Seminar Program. However, where available, references to related information are provided with the seminar title.
- Wednesday, April 23: Joyce Cantrell, CAPT/MC/USN, MD, MPH, GLP Test Facilities Manager, AFRRI: AFRRI and the USU Global Health Program.
- Wednesday, March 19: David L. Bolduc, PhD, Research Microbiologist, AFRRI: The development of radiation injury algorithms using blood parameters from a nonhuman primate model: A pilot study. Related information:
- Wednesday, March 12: John F. Kalinich, PhD, Internal Contamination and Metal Toxicity Program, AFRRI: Decorporation of internalized radionuclides. Related information:
- Wednesday, February 26: Dr. William F. Blakely, PhD, Biological Dosimetry Program, AFRRI: Further updates on translational biodosimetry research activities. Related information:
- Wednesday, February 19: Natalia I. Ossetrova, PhD, Research Biologist, Biological Dosimetry Program, AFRRI: Nonhuman primate radiation model with limited and fully supportive care for biodosimetry. Related information:
- Wednesday, February 12: Michael R. Landauer, PhD, Research Toxicologist, AFRRI: Intramuscular delivery of genistein nanoparticles as a medical radiation countermeasure agent: New developments. Related information:
- Wednesday, February 5: Vijay K. Singh, PhD, Associate Professor, Acting Chair, Radiation Biology Department, F. Edward Hébert School of Medicine, Countermeasure Development Program, AFRRI, USUHS: Advanced development of gamma-tocotrienol as a radiation countermeasure. Related information:
- Wednesday, January 29: Juliann G. Kiang, PhD, Combined Injury: Radiation with Other Insults
Program, AFRRI: Synergy between radiation and hemorrhage: Events beyond ARS. Related information:
- Wednesday January 15: Sibyl N. Swift, PhD, Research Biologist, Countermeasure Development Program, AFRRI: Traumatic brain injuries (TBI) disrupt hypothalamic-pituitary-adrenal (HPA) axis feedback in male mice. Related information:
- Wednesday, January 8, 2014: C. Chandra Kumar, PhD, MBA, Executive Director, Onconova Therapeutics, Pennington, NJ: Akt/PKB cell survival signaling pathway. Related information: